Das IOMP – WHO Joint Webinar on World Patient Safety Day 2022 findet statt am Mittwoch, den 14. September 2022 um 12 pm GMT.

Organisation: John Damilakis, IOMP

Moderation: Eva Bezak, IOMP

Referenten/Referentinnen:

Prof. John Damilakis, IOMP: professor and chairman at the Department of Medical Physics, School of Medicine, University of Crete and director of the Department of Medical Physics of the University Hospital of Heraklion, Greece. He is President of the ‘International Organization for Medical Physics’ (IOMP), Past President of the ‘European Alliance for Medical Radiation Protection Research’ (EURAMED), of the ‘European Federation of Organizations for Medical Physics’ (EFOMP) and of the ‘Hellenic Association of Medical Physics’. Prof. Damilakis is a member of the ICRP Committee 3 and member of the steering committee of the ‘EuroSafe Imaging Campaign’ of the European Society of Radiology. He is coordinator or an active research member of several European and national projects. As a Visiting Professor he has given lectures on dosimetry and radiation protection in Boston University, USA. His publications have been focused on medical radiation protection and dosimetry and also on Artificial Intelligence in medical imaging. He is editor, author or co-author of several books. Number of publications in PubMed: 243, number of citations: 8286, h-index 48 (Google Scholar). He has received several awards for his work.

Dr. Emilie van Deventer, WHO: Emilie van Deventer is the Head of the Radiation and Health Unit at the World Health Organization in Geneva, Switzerland. This programme covers the public health aspects of both ionizing and non-ionizing radiation safety and provides information and guidance to national authorities on radiation protection and health. She is responsible, inter alia, for the WHO International EMF Project, the Global UV project and radon activities.  Before joining WHO in 2000, she was a chaired professor of Electrical and Computer Engineering at the University of Toronto, Canada. She holds a PhD from the University of Michigan, USA and an honorary doctorate (doctor honoris causa) from the University of San Marcos, Lima, Peru.

Dr. Erik Briers, EPCC: Erik Briers holds a doctorate in Chemistry from the University of Leuven, Belgium. Since his promotion in 1979 he has been involved in laboratory medicine. He founded in 1982 the diagnostic company Eco-Bio diagnostics and served as its CEO until 1990. In this function he developed a diagnostic test for the detection of Aspergillus antigens with a fast assay allowing the potential curative treatment of patients with disseminated aspergillosis, a deadly disease. This test has been approved by the FDA. He has been a guest lecturer for the subject “Applied immunology” within the Master study programme Biochemical Engineering at the University of Leuven 2009-2016.
Erik Briers was the Executive Director of the European Cancer Patient Coalition (ECPC) (2012-2013) and ad interim executive director of EPPOSI (The European Platform for Patient Organizations Science and Industry) (2014). He was active at the European Medicine Agency (EMA) at the Patient and Consumer working party (PCWP) and later was appointed by the EU commission as an alternate patient member of the Committee on Advanced Therapies (CAT) (2016-2019).
He is board member and vice chairman of Europa Uomo. He is a member of the Guidelines Panel on the treatment of prostate cancer of the European Association of Urology (EAU) since 2013. He is since 2013 member of the patient advisory board of the European Society of Radiology (ESR-PAG) and has given many presentations at the occasion of the yearly European Congress of Radiology (ECR). He is vice-president of Us Too Belgium and the chief editor of PROSTAATinfo the magazine of the organization. He serves as a member of advisory boards of several scientific organizations.

Registrierungen können unter dem folgenden Link erfolgen: https://us02web.zoom.us/webinar/register/WN_jMGfh1GrS4eJ9KosQ4gi2g